Teva Pharmaceuticals USA Inc recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis
Recalled August 10, 2022 · FDA recall D-1302-2022 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications: below specification limits for dissolution. · FDA Class II
Units
8022 bottles
Sold at
Nationwide in the USA and Puerto Rico
Description
Failed Dissolution Specifications: below specification limits for dissolution.
Product
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.
Manufacturer(s)
Teva Pharmaceuticals USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →